Home/Filings/4/0001178913-23-003971
4//SEC Filing

Toledano Miranda Jayne 4

Accession 0001178913-23-003971

CIK 0001638097other

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 8:27 AM ET

Size

7.7 KB

Accession

0001178913-23-003971

Insider Transaction Report

Form 4
Period: 2023-12-22
Toledano Miranda Jayne
DirectorChief Executive Officer
Transactions
  • Purchase

    Warrants (right to buy)

    2023-12-22$0.13/sh+23,952$2,99423,952 total
    Exercise: $1.00From: 2023-12-22Exp: 2028-12-22Ordinary Shares, par value NIS 0.0000769 per share (23,952 underlying)
  • Purchase

    Ordinary Shares, par value NIS 0.0000769 per share

    2023-12-22$0.71/sh+23,952$17,006110,752 total
Footnotes (1)
  • [F1]The Reporting Person entered into a Securities Purchase Agreement with the Issuer on December 20, 2023, pursuant to which, on December 22, 2023, the Reporting Person acquired an aggregate of 23,952 units for a purchase price of $0.835 per unit, each unit consisting of one share of the Issuer's ordinary shares, par value NIS 0.0000769 per share ("Ordinary Shares"), and one warrant, exercisable to purchase an Ordinary Share at an exercise price of $1.00 per share. The purchase price for each unit included $0.125 for the warrant in accordance with Nasdaq rules.

Documents

1 file

Issuer

Entera Bio Ltd.

CIK 0001638097

Entity typeother

Related Parties

1
  • filerCIK 0001686530

Filing Metadata

Form type
4
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 8:27 AM ET
Size
7.7 KB